Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. Cash on Hand 2020–2025
Insight Molecular Diagnostics Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Insight Molecular Diagnostics Inc. cash on hand as of December 31, 2025: 11.6M, a 34.12% increase year-over-year.
- Insight Molecular Diagnostics Inc. cash on hand for 2025 were 11.6M, a 34.12% increase from 2024.
- Insight Molecular Diagnostics Inc. cash on hand for 2024 were 8.6M, a 8.44% decrease from 2023.
- Insight Molecular Diagnostics Inc. cash on hand for 2023 were 9.4M, a 52.82% decrease from 2022.
- Insight Molecular Diagnostics Inc. cash on hand for 2022 were 20.0M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Insight Molecular Diagnostics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $12 |
| 2024 | $9 |
| 2023 | $9 |
| 2022 | $20 |
| 2021 | $33 |
| 2020 | $7 |
Insight Molecular Diagnostics Inc. Cash on Hand — FAQ
Insight Molecular Diagnostics Inc. (IMDX) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMDX's cash on hand history?
The chart and table above show Insight Molecular Diagnostics Inc.'s cash on hand by year and by quarter, including the growth rate.